Please use this identifier to cite or link to this item:
https://hdl.handle.net/2440/134597
Citations | ||
Scopus | Web of Science® | Altmetric |
---|---|---|
?
|
?
|
Type: | Journal article |
Title: | Immunoglobulin E sensitization to mammalian oligosaccharide galactose-α-1,3 (α-Gal) is associated with noncalcified plaque, obstructive coronary artery disease, and ST-segment-elevated myocardial infarction |
Other Titles: | Immunoglobulin E sensitization to mammalian oligosaccharide galactose-alpha-1,3 (alpha-Gal) is associated with noncalcified plaque, obstructive coronary artery disease, and ST-segment-elevated myocardial infarction |
Author: | Vernon, S.T. Kott, K.A. Hansen, T. Finemore, M. Baumgart, K.W. Bhindi, R. Yang, J. Hansen, P.S. Nicholls, S.J. Celermajer, D.S. Ward, M.R. van Nunen, S.A. Grieve, S.M. Figtree, G.A. |
Citation: | Arteriosclerosis, Thrombosis and Vascular Biology, 2022; 42(3):352-361 |
Publisher: | American Heart Association |
Issue Date: | 2022 |
ISSN: | 1079-5642 1524-4636 |
Statement of Responsibility: | Stephen T. Vernon, Katharine A. Kott, Thomas Hansen, Meghan Finemore, Karl W. Baumgart, Ravinay Bhindi, Jean Yang, Peter S. Hansen, Stephen J. Nicholls, David S. Celermajer, Michael R. Ward, Sheryl A. van Nunen, Stuart M. Grieve, Gemma A. Figtree |
Abstract: | Background: Treating known risk factors for coronary artery disease (CAD) has substantially reduced CAD morbidity and mortality. However, a significant burden of CAD remains unexplained. Immunoglobulin E sensitization to mammalian oligosaccharide galactose-α-1,3-galactose (α-Gal) was recently associated with CAD in a small observational study. We sought to confirm that α-Gal sensitization is associated with CAD burden, in particular noncalcified plaque. Additionally, we sort to assess whether that α-Gal sensitization is associated with ST-segment–elevated myocardial infarction (STEMI) Methods: We performed a cross-sectional analysis of participants enrolled in the BioHEART cohort study. We measured α-Gal specific-immunoglobulin E antibodies in serum of 1056 patients referred for CT coronary angiography for suspected CAD and 100 selected patients presenting with STEMI, enriched for patients without standard modifiable risk factors. CT coronary angiograms were assessed using coronary artery calcium scores and segmental plaque scores. Results: α-Gal sensitization was associated with presence of noncalcified plaque (odds ratio, 1.62 [95% CI, 1.04–2.53], P=0.03) and obstructive CAD (odds ratio, 2.05 [95% CI, 1.29-3.25], P=0.002), independent of age, sex, and traditional risk factors. The α-Gal sensitization rate was 12.8-fold higher in patients with STEMI compared with matched healthy controls and 2.2-fold higher in the patients with STEMI compared with matched stable CAD patients (17% versus 1.3%, P=0.01 and 20% versus 9%, P=0.03, respectively). Conclusions: α-Gal sensitization is independently associated with noncalcified plaque burden and obstructive CAD and occurs at higher frequency in patients with STEMI than those with stable or no CAD. These findings may have implications for individuals exposed to ticks, as well as public health policy. |
Keywords: | Atherosclerosis; biomarkers; coronary artery disease; risk factors; smoking |
Rights: | © 2022 American Heart Association, Inc. |
DOI: | 10.1161/ATVBAHA.121.316878 |
Grant ID: | http://purl.org/au-research/grants/nhmrc/11359290 |
Published version: | http://dx.doi.org/10.1161/atvbaha.121.316878 |
Appears in Collections: | Medicine publications |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.